Ignite Creation Date:
2024-05-06 @ 7:16 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05954442
Status:
RECRUITING
Last Update Posted:
2024-01-16
First Post:
2023-07-13
Brief Title:
Everolimus With Investigators Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer TNBC With Luminal Androgen Receptor LAR Subtype
Sponsor:
Organization:
Fudan University